CN Patent

CN101450212A — 提高生物利用度的固体药物分散体

Assigned to Pfizer Products Inc · Expires 2009-06-10 · 17y expired

What this patent protects

含有微溶药物和羟丙基甲基纤维素乙酸琥珀酸酯(HPMCAS)的喷雾干燥固体分散体，它能够在使用环境中提供提高了的水溶解度和/或生物利用度。

USPTO Abstract

含有微溶药物和羟丙基甲基纤维素乙酸琥珀酸酯(HPMCAS)的喷雾干燥固体分散体，它能够在使用环境中提供提高了的水溶解度和/或生物利用度。

Drugs covered by this patent

Patent Metadata

Patent number
CN101450212A
Jurisdiction
CN
Classification
—
Expires
2009-06-10
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.